Savant Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25.9M | Buy |
47,809
+39,271
| +460% | +$18.9M | 0.08% | 169 |
|
|
2026
Q1 | $4.2M | Buy |
8,538
+582
| +7% | +$316K | 0.02% | 291 |
|
|
2025
Q4 | $4.61M | Buy |
7,956
+884
| +13% | +$500K | 0.03% | 257 |
|
|
2025
Q3 | $3.43M | Buy |
7,072
+509
| +8% | +$237K | 0.02% | 287 |
|
|
2025
Q2 | $2.66M | Sell |
6,563
-186
| -3% | -$77.8K | 0.02% | 312 |
|
|
2025
Q1 | $3.36M | Sell |
6,749
-1,076
| -14% | -$583K | 0.03% | 239 |
|
|
2024
Q4 | $4.07M | Buy |
7,825
+17
| +0.2% | +$9.35K | 0.03% | 269 |
|
|
2024
Q3 | $4.83M | Buy |
7,808
+2,514
| +47% | +$1.49M | 0.04% | 229 |
|
|
2024
Q2 | $2.93M | Sell |
5,294
-69
| -1% | -$39.5K | 0.03% | 291 |
|
|
2024
Q1 | $3.12M | Sell |
5,363
-2,155
| -29% | -$1.21M | 0.04% | 254 |
|
|
2023
Q4 | $3.99M | Buy |
7,518
+175
| +2% | +$84.7K | 0.05% | 198 |
|
|
2023
Q3 | $3.72M | Sell |
7,343
-758
| -9% | -$404K | 0.06% | 191 |
|
|
2023
Q2 | $4.23M | Buy |
8,101
+866
| +12% | +$467K | 0.07% | 175 |
|
|
2023
Q1 | $4.17M | Buy |
7,235
+3,608
| +99% | +$2.03M | 0.08% | 154 |
|
|
2022
Q4 | $2M | Buy |
3,627
+18
| +0.5% | +$9.54K | 0.05% | 164 |
|
|
2022
Q3 | $1.83M | Sell |
3,609
-53
| -1% | -$29.7K | 0.06% | 162 |
|
|
2022
Q2 | $1.99M | Buy |
3,662
+373
| +11% | +$205K | 0.06% | 149 |
|
|
2022
Q1 | $1.94M | Sell |
3,289
-106
| -3% | -$60.9K | 0.06% | 158 |
|
|
2021
Q4 | $2.27M | Buy |
3,395
+89
| +3% | +$55.6K | 0.07% | 140 |
|
|
2021
Q3 | $1.89M | Sell |
3,306
-14
| -0.4% | -$7.68K | 0.07% | 152 |
|
|
2021
Q2 | $1.68M | Buy |
3,320
+152
| +5% | +$71.7K | 0.07% | 152 |
|
|
2021
Q1 | $1.45M | Sell |
3,168
-24
| -0.8% | -$11.5K | 0.08% | 156 |
|
|
2020
Q4 | $1.49M | Sell |
3,192
-16
| -0.5% | -$7.5K | 0.09% | 143 |
|
|
2020
Q3 | $1.42M | Buy |
3,208
+249
| +8% | +$103K | 0.1% | 141 |
|
|
2020
Q2 | $1.07M | Buy |
2,959
+59
| +2% | +$19.8K | 0.08% | 160 |
|
|
2020
Q1 | $822K | Buy |
2,900
+401
| +16% | +$126K | 0.08% | 175 |
|
|
2019
Q4 | $812K | Buy |
2,499
+55
| +2% | +$16.7K | 0.1% | 153 |
|
|
2019
Q3 | $712K | Buy |
2,444
+129
| +6% | +$36.9K | 0.1% | 151 |
|
|
2019
Q2 | $680K | Sell |
2,315
-160
| -6% | -$44.1K | 0.1% | 158 |
|
|
2019
Q1 | $677K | Sell |
2,475
-295
| -11% | -$73.4K | 0.13% | 125 |
|
|
2018
Q4 | $620K | Sell |
2,770
-21
| -0.8% | -$4.93K | 0.13% | 124 |
|
|
2018
Q3 | $681K | Buy |
2,791
+9
| +0.3% | +$2.07K | 0.12% | 127 |
|
|
2018
Q2 | $576K | Hold |
2,782
| – | – | 0.12% | 132 |
|
|
2018
Q1 | $574K | Sell |
2,782
-85
| -3% | -$17.8K | 0.12% | 134 |
|
|
2017
Q4 | $544K | Buy |
2,867
+54
| +2% | +$10.3K | 0.11% | 140 |
|
|
2017
Q3 | $532K | Buy |
2,813
+20
| +0.7% | +$3.62K | 0.12% | 129 |
|
|
2017
Q2 | $487K | Buy |
2,793
+29
| +1% | +$4.87K | 0.12% | 139 |
|
|
2017
Q1 | $425K | Buy |
2,764
+1,056
| +62% | +$161K | 0.11% | 154 |
|
|
2016
Q4 | $241K | Sell |
1,708
-10
| -0.6% | -$1.47K | 0.06% | 223 |
|
|
2016
Q3 | $273K | Buy |
1,718
+20
| +1% | +$3.08K | 0.08% | 197 |
|
|
2016
Q2 | $251K | Sell |
1,698
-90
| -5% | -$13.3K | 0.07% | 210 |
|
|
2016
Q1 | $253K | Sell |
1,788
-422
| -19% | -$56.6K | 0.08% | 189 |
|
|
2015
Q4 | $314K | Buy |
+2,210
| New | +$295K | 0.1% | 159 |
|
Other funds holding TMO
Savant Capital's TMO Position: Q2 2026 in Review
Savant Capital increased its Thermo Fisher Scientific (TMO) stake by 460% in Q2 2026, buying an estimated $18.9M and bringing the position to 47,809 shares worth $25.9M. The position accounts for 0.08% of the portfolio, ranked #169.
Savant Capital first reported a position in TMO in Q4 2015 and has held it in 43 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Savant Capital held 47,809 shares of Thermo Fisher Scientific worth $25.9M as of Q2 2026.
- Savant Capital bought 39,271 Thermo Fisher Scientific shares in Q2 2026, an estimated $18.9M.
- Thermo Fisher Scientific made up 0.08% of Savant Capital's portfolio in Q2 2026, its #169 holding.
- Savant Capital first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 43 quarters since.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.